62 related articles for article (PubMed ID: 29601615)
1. Research of primary hyperhidrosis in students of medicine of the State of Sergipe, Brazil.
Lima SO; Aragão JF; Machado Neto J; Almeida KB; Menezes LM; Santana VR
An Bras Dermatol; 2015; 90(5):661-5. PubMed ID: 26560211
[TBL] [Abstract][Full Text] [Related]
2. Navigating in the fog. Facing delays, rejection and ignorance when seeking help for primary hyperhidrosis.
Shayesteh A; Gerdsdorff F; Persson M; Brulin C; Nylander E
Int J Qual Stud Health Well-being; 2021 Dec; 16(1):1930642. PubMed ID: 34053415
[TBL] [Abstract][Full Text] [Related]
3. Primary hyperhidrosis: From a genetics point of view.
Parveen A; Abbas S; Mehmood N; Patafi MAM; Wajid U; Luqman M; Arshad S
J Family Med Prim Care; 2023 Dec; 12(12):3028-3032. PubMed ID: 38361865
[TBL] [Abstract][Full Text] [Related]
4. Hyperhidrosis: a patient's perspective.
O'Reilly M; Affleck A
Clin Exp Dermatol; 2024 Apr; 49(5):528-529. PubMed ID: 38000894
[No Abstract] [Full Text] [Related]
5. Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: A Double-Blind, Randomized, Split-Site, Vehicle-Controlled Study.
Lueangarun S; Sermsilp C; Tempark T
Dermatol Surg; 2018 Aug; 44(8):1094-1101. PubMed ID: 29659406
[TBL] [Abstract][Full Text] [Related]
6. Investigation on aetiological factors in patients with hyperhidrosis.
Akbaş A; Kilinç F
Cutan Ocul Toxicol; 2018 Dec; 37(4):344-349. PubMed ID: 29669433
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histological evaluation of a single high energy microwave treatment for primary axillary hyperhidrosis in Asians: A prospective, randomized, controlled, split-area comparative trial.
Kaminaka C; Mikita N; Inaba Y; Kunimoto K; Okuhira H; Jinnin M; Kao B; Tanino R; Tanioka K; Shimokawa T; Yamamoto Y
Lasers Surg Med; 2019 Sep; 51(7):592-599. PubMed ID: 30811620
[TBL] [Abstract][Full Text] [Related]
8. Hyperhidrosis and its impact on those living with it.
Lenefsky M; Rice ZP
Am J Manag Care; 2018 Dec; 24(23 Suppl):S491-S495. PubMed ID: 30589248
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic thoracic sympathicotomy for primary palmar hyperhidrosis: A retrospective multicenter study in China.
Chen J; Liu Y; Yang J; Hu J; Peng J; Gu L; Deng B; Li Y; Gao B; Sheng Q; Chen G; Zhang Y; Xie D; Wang J; Zhan H; Tu Y
Surgery; 2019 Dec; 166(6):1092-1098. PubMed ID: 31378477
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Hyperhidrosis on Quality of Life: A Review of the Literature.
Parashar K; Adlam T; Potts G
Am J Clin Dermatol; 2023 Mar; 24(2):187-198. PubMed ID: 36622502
[TBL] [Abstract][Full Text] [Related]
11. Knowledge of surgical management of hyperhidrosis among primary care physicians and the general public.
Lee ACH; Ferguson MK
Interact Cardiovasc Thorac Surg; 2022 May; 34(5):791-798. PubMed ID: 35015865
[TBL] [Abstract][Full Text] [Related]
12. Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double-blind, vehicle-controlled study.
Yokozeki H; Fujimoto T; Wanatabe S; Ogawa S; Fujii C
J Dermatol; 2022 Jan; 49(1):86-94. PubMed ID: 34636057
[TBL] [Abstract][Full Text] [Related]
13. A systematic evidence-based review of treatments for primary hyperhidrosis.
Stuart ME; Strite SA; Gillard KK
J Drug Assess; 2020 Dec; 10(1):35-50. PubMed ID: 33489435
[TBL] [Abstract][Full Text] [Related]
14. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok RD; Quiring J; Drew J; Pariser DM
Am J Clin Dermatol; 2019 Aug; 20(4):593-604. PubMed ID: 31111409
[TBL] [Abstract][Full Text] [Related]
15. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
Hebert AA; Glaser DA; Green L; Werschler WP; Forsha DW; Drew J; Gopalan R; Pariser DM
Pediatr Dermatol; 2019 Jan; 36(1):89-99. PubMed ID: 30451318
[TBL] [Abstract][Full Text] [Related]
16. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials.
Pariser DM; Hebert AA; Drew J; Quiring J; Gopalan R; Glaser DA
Am J Clin Dermatol; 2019 Feb; 20(1):135-145. PubMed ID: 30378087
[TBL] [Abstract][Full Text] [Related]
17. Understanding Patient Experience With Hyperhidrosis: A National Survey of 1,985 Patients.
Glaser DA; Hebert A; Pieretti L; Pariser D
J Drugs Dermatol; 2018 Apr; 17(4):392-396. PubMed ID: 29601615
[TBL] [Abstract][Full Text] [Related]
18. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.
Strutton DR; Kowalski JW; Glaser DA; Stang PE
J Am Acad Dermatol; 2004 Aug; 51(2):241-8. PubMed ID: 15280843
[TBL] [Abstract][Full Text] [Related]
19. Hyperhidrosis: prevalence and impact on quality of life.
Hasimoto EN; Cataneo DC; Reis TAD; Cataneo AJM
J Bras Pneumol; 2018; 44(4):292-298. PubMed ID: 30066741
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
